173 related articles for article (PubMed ID: 22655969)
1. Rapid clinical and radiographic improvement after intrathecal trastuzumab and methotrexate in a patient with HER-2 positive leptomeningeal metastases.
Martens J; Venuturumilli P; Corbets L; Bestul D
Acta Oncol; 2013 Jan; 52(1):175-8. PubMed ID: 22655969
[No Abstract] [Full Text] [Related]
2. Complete response in HER2+ leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab.
Oliveira M; Braga S; Passos-Coelho JL; Fonseca R; Oliveira J
Breast Cancer Res Treat; 2011 Jun; 127(3):841-4. PubMed ID: 21369716
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
4. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report.
Stemmler HJ; Mengele K; Schmitt M; Harbeck N; Laessig D; Herrmann KA; Schaffer P; Heinemann V
Anticancer Drugs; 2008 Sep; 19(8):832-6. PubMed ID: 18690096
[TBL] [Abstract][Full Text] [Related]
5. [Trastuzumab's association with cerebral metastases and meningeal carcinomatosis in a patient with HER2-positive breast cancer].
Ayuga Loro F; Jiménez Caballero PE; Martínez Barbeito MB; Cruz Mora MA
Med Clin (Barc); 2009 Jul; 133(7):279-80. PubMed ID: 19615485
[No Abstract] [Full Text] [Related]
6. Long-term survival in an untreated patient with leptomeningeal carcinomatosis from breast primary.
Singh SK; Bansal VK; Wiley EL; Valyi-Nagy T; Villano JL
Clin Neurol Neurosurg; 2013 Mar; 115(3):362-4. PubMed ID: 22727367
[No Abstract] [Full Text] [Related]
7. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
8. Role of intrathecal rituximab and trastuzumab in the management of leptomeningeal carcinomatosis.
Perissinotti AJ; Reeves DJ
Ann Pharmacother; 2010 Oct; 44(10):1633-40. PubMed ID: 20807868
[TBL] [Abstract][Full Text] [Related]
9. [Intrathecal methotrexate chemotherapy for leptomeningeal carcinomatosis].
Kullmann T; Gauthier H; le Maignan C; Szabó A; Culine S
Orv Hetil; 2012 Sep; 153(35):1385-8. PubMed ID: 22935431
[TBL] [Abstract][Full Text] [Related]
10. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?].
Gutierrez M; Lyazidi S; Brasseur L; Cvitkovic F; Le Scodan R
Bull Cancer; 2011 Apr; 98(4):417-24. PubMed ID: 21540147
[TBL] [Abstract][Full Text] [Related]
11. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
Mandrawa CL; Stewart J; Fabinyi GC; Walker SP
Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):372-6. PubMed ID: 21806575
[TBL] [Abstract][Full Text] [Related]
12. [The requirements to clinicopathology about targeted therapy for breast cancer].
Jiang ZF; Shen G
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):435-7. PubMed ID: 17845752
[No Abstract] [Full Text] [Related]
13. Lapatinib plus capecitabine resolved human epidermal growth factor receptor 2-positive brain metastases.
Glück S; Castrellon A
Am J Ther; 2009; 16(6):585-90. PubMed ID: 19287304
[TBL] [Abstract][Full Text] [Related]
14. Leptomeningeal carcinomatosis from breast cancer treated with intrathecal topotecan with concomitant intravenous eribulin.
Salgia S; Fleming GF; Lukas RV
J Clin Neurosci; 2014 Jul; 21(7):1250-1. PubMed ID: 24412296
[TBL] [Abstract][Full Text] [Related]
15. Incidence of brain metastases in early stage HER2 3+ breast cancer patients; is there a role for brain CT in asymptomatic patients?
Tomasevic ZI; Rakocevic Z; Tomasevic ZM; Milovanovic Z; Inic M; Kolarevic D; Lukic V; Kovac Z
J BUON; 2012; 17(2):249-53. PubMed ID: 22740201
[TBL] [Abstract][Full Text] [Related]
16. Bi-weekly very-high-dose lapatinib: an easy-to-use active option in HER-2-positive breast cancer patients with meningeal carcinomatosis.
Lavaud P; Rousseau B; Ajgal Z; Arrondeau J; Huillard O; Alexandre J; Hulin A; Goldwasser F
Breast Cancer Res Treat; 2016 May; 157(1):191-2. PubMed ID: 27106482
[No Abstract] [Full Text] [Related]
17. Intrathecal administration of anti-HER2 treatment for the treatment of meningeal carcinomatosis in breast cancer: A metanalysis with meta-regression.
Zagouri F; Zoumpourlis P; Le Rhun E; Bartsch R; Zografos E; Apostolidou K; Dimopoulos MA; Preusser M
Cancer Treat Rev; 2020 Aug; 88():102046. PubMed ID: 32599393
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report.
Cavanna L; Rocchi A; Gorgni S; Ambroggi M; Foroni RP; Ubbiali A; Civardi G
J Clin Oncol; 2011 May; 29(13):e367-8. PubMed ID: 21300922
[No Abstract] [Full Text] [Related]
19. Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis.
Zagouri F; Sergentanis TN; Bartsch R; Berghoff AS; Chrysikos D; de Azambuja E; Dimopoulos MA; Preusser M
Breast Cancer Res Treat; 2013 May; 139(1):13-22. PubMed ID: 23588955
[TBL] [Abstract][Full Text] [Related]
20. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
